search
Back to results

Lung Cancer Screening Protocol (I-STEP)

Primary Purpose

Lung Cancer Screening

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Toolbox for Lung Cancer Screening
Sponsored by
Washington University School of Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Lung Cancer Screening

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • To be eligible to participate in the trial, screening centers have to be existing members of the BJC Collaborative.
  • Primary Care Providers have to have a referral relationship with the screening center; serve adult patients who may be screening-eligible, and are willing to interact with the referral site to implement referral for LDCT.

Exclusion Criteria:

There are not any exclusion criteria for the study

Sites / Locations

  • Southern Illinois Healthcare
  • Decatur Memorial Hospital
  • Sarah Bush Lincoln Health System
  • Memorial Health System
  • Washington University School of Medicine
  • BJC HealthCare, Barnes-Jewish St. Peters Hospital
  • CoxHealth

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Lung Cancer Screening Toolbox

Arm Description

WU Staff will train local screening staff using a train-the-trainer model three months prior to the intervention and will provide technical assistance on an ongoing basis. During the 3 hour train-the-trainer session, the selected staff from the referral sites will learn about the program, receive an orientation to the toolbox elements, and discuss how to adapt the elements of the toolbox to their referral sites.

Outcomes

Primary Outcome Measures

Number of initial low-dose CT (LDCT) scan screenings per month per screening center
-Screening will be defined as completed initial screen for lung cancer

Secondary Outcome Measures

Number of primary care providers who refer at least two patients per month for LDCT
Percent of patients referred who are screen-eligible
Defined as the number of screen-eligible patients divided by the total of screening procedures performed
Percent of patients referred who complete screening
Defined as the number of patients referred for screening divided by the total number of screening procedures performed.

Full Information

First Posted
May 17, 2019
Last Updated
April 6, 2021
Sponsor
Washington University School of Medicine
Collaborators
BJC HealthCare, Barnes-Jewish St. Peters Hospital, Decatur Memorial Hospital, Memorial Health System, Sarah Bush Lincoln Health System, Southern Illinois Healthcare, Cox Health Systems
search

1. Study Identification

Unique Protocol Identification Number
NCT03958253
Brief Title
Lung Cancer Screening Protocol
Acronym
I-STEP
Official Title
I-STEP: Increasing Screening Through Engaging Primary Care Providers
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
April 22, 2019 (Actual)
Primary Completion Date
March 31, 2021 (Actual)
Study Completion Date
March 31, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Washington University School of Medicine
Collaborators
BJC HealthCare, Barnes-Jewish St. Peters Hospital, Decatur Memorial Hospital, Memorial Health System, Sarah Bush Lincoln Health System, Southern Illinois Healthcare, Cox Health Systems

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The successful implementation of lung cancer screening across diverse setting requires working with the community and primary care practices. Collaborating across diverse community-based sites will employ local knowledge and culture in the understanding of the health problem and identifying and implementing solutions that are appropriate for all partners (patients, primary care, referral centers). Enhanced, culturally-competent communication with patients at high risk for lung cancer can narrow inequities in screening awareness, referral, and utilization, as well as improve lung cancer outcomes across diverse patients and communities. Promoting partnerships among physicians, staff, and patients; creating routines; and tailoring materials to each clinician's situation have been show to increase the proportion of patients receiving screening.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lung Cancer Screening

7. Study Design

Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Model Description
This is a stepped wedge cluster randomized trial in which the intervention condition (toolbox) is sequentially assigned to participating hospitals (screening centers) in 6 clusters at different time-delays and where pre-intervention data serves as the control. By the end of the study, all clusters have been exposed to the intervention and each cluster has provided data for the control and intervention conditions. Independent samples of primary care providers are enrolled at each period within a cluster, thus, it is a repeated cross-sectional study. The order of the entry into the intervention phase is randomized based on levels of readiness
Masking
None (Open Label)
Allocation
Randomized
Enrollment
193 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Lung Cancer Screening Toolbox
Arm Type
Experimental
Arm Description
WU Staff will train local screening staff using a train-the-trainer model three months prior to the intervention and will provide technical assistance on an ongoing basis. During the 3 hour train-the-trainer session, the selected staff from the referral sites will learn about the program, receive an orientation to the toolbox elements, and discuss how to adapt the elements of the toolbox to their referral sites.
Intervention Type
Other
Intervention Name(s)
Toolbox for Lung Cancer Screening
Intervention Description
-Toolbox of evidence-based elements that a primary care or referral site could implement to address known barriers to screening and referral, as well as required elements for screening. These elements will be designed to be adaptable to the unique needs and screening processes of the participating practices. Patient education materials Primary care practice educational materials Pack-years/eligibility calculator Local referral process guide Smoking cessation materials and support Shared decision-making guide LDCT best practice guidelines
Primary Outcome Measure Information:
Title
Number of initial low-dose CT (LDCT) scan screenings per month per screening center
Description
-Screening will be defined as completed initial screen for lung cancer
Time Frame
Completion of study (estimated to be 21 months)
Secondary Outcome Measure Information:
Title
Number of primary care providers who refer at least two patients per month for LDCT
Time Frame
Completion of study (estimated to be 21 months)
Title
Percent of patients referred who are screen-eligible
Description
Defined as the number of screen-eligible patients divided by the total of screening procedures performed
Time Frame
Completion of study (estimated to be 21 months)
Title
Percent of patients referred who complete screening
Description
Defined as the number of patients referred for screening divided by the total number of screening procedures performed.
Time Frame
Completion of study (estimated to be 21 months)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: To be eligible to participate in the trial, screening centers have to be existing members of the BJC Collaborative. Primary Care Providers have to have a referral relationship with the screening center; serve adult patients who may be screening-eligible, and are willing to interact with the referral site to implement referral for LDCT. Exclusion Criteria: There are not any exclusion criteria for the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Aimee S James, Ph.D., MPH
Organizational Affiliation
Washington University School of Medicine
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Graham A Colditz, M.D., DrPH
Organizational Affiliation
Washington University School of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Southern Illinois Healthcare
City
Carbondale
State/Province
Illinois
ZIP/Postal Code
62901
Country
United States
Facility Name
Decatur Memorial Hospital
City
Decatur
State/Province
Illinois
ZIP/Postal Code
62526
Country
United States
Facility Name
Sarah Bush Lincoln Health System
City
Mattoon
State/Province
Illinois
ZIP/Postal Code
61938
Country
United States
Facility Name
Memorial Health System
City
Springfield
State/Province
Illinois
ZIP/Postal Code
62702
Country
United States
Facility Name
Washington University School of Medicine
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63110
Country
United States
Facility Name
BJC HealthCare, Barnes-Jewish St. Peters Hospital
City
Saint Peters
State/Province
Missouri
ZIP/Postal Code
63376
Country
United States
Facility Name
CoxHealth
City
Springfield
State/Province
Missouri
ZIP/Postal Code
65802
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Practice level and screening center aggregate numbers may be made available to investigators whose proposed use of the data has been approved by an independent review committee ("learned intermediary") identified for this purpose
IPD Sharing Time Frame
Beginning in 3 months and ending 5 years following article publication
IPD Sharing Access Criteria
Proposals should be directed to aimeejames@wustl.edu. To gain access, data requestors will need to sign a data access agreement.
Citations:
PubMed Identifier
32184197
Citation
Salazar AS, Sekhon S, Rohatgi KW, Nuako A, Liu J, Harriss C, Brennan E, LaBeau D, Abdalla I, Schulze C, Muenks J, Overlot D, Higgins JA, Jones LS, Swick C, Goings S, Badiu J, Walker J, Colditz GA, James AS. A stepped-wedge randomized trial protocol of a community intervention for increasing lung screening through engaging primary care providers (I-STEP). Contemp Clin Trials. 2020 Apr;91:105991. doi: 10.1016/j.cct.2020.105991. Epub 2020 Mar 14.
Results Reference
derived
Links:
URL
http://www.siteman.wustl.edu
Description
Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Learn more about this trial

Lung Cancer Screening Protocol

We'll reach out to this number within 24 hrs